Common signs of this disease include:
- Blurred vision.
- Need for more light to read.
- Reduced appreciate of colors.
- Difficulty in recognizing faces.
- Spot in your central vision.
There are many layers of tiny cells present in Macula. As we grow older, these tiny cells do not function adequately. If they do not, then there is high probability of deposits building up in the retina. Also, new blood vessels will grow inside the retina. The new vessels are delicate, and often bleed easily. Under these different conditions, your retina will not function properly. You will have a distorted or blurred vision, and sometimes, no vision. AMD has been identified as a common condition affecting people more than 50 years old. In a few cases, AMD develops slowly, affecting people at a later stage. In other cases, its progression can be evidently faster. When Macula or central portion of your eye deteriorates, the condition is called Macular degeneration. It is medically acknowledged as an incurable eye disease. Under macular degeneration, an individual will not be able to see properly. In severe cases, the person will suffer total vision loss. When macula is damaged, its functioning process of recording the images and sending a brain signal via the optic nerve suffers.
The prevalence of age-related macular degeneration is increasing in Asia due to increase in life expectancy and rising incidents of diabetes among the younger population. As per the Centre for Eye Research Australia, prevalence of diabetic retinopathy among people ranged between 17% and 22% in India, and 43.1% in rural China in 2012. Age-related eye diseases such as glaucoma, cataract, diabetic retinopathy, and age-related macular degeneration, are the leading causes of visual impairment and blindness in North America. According to the American Academy of Ophthalmology, approximately 22 million Americans aged 40 and above were affected by cataract and 2.3 million Americans were affected by glaucoma in 2011.
This procedure has been used to treat the disease in an effective manner. Radiotherapy in combination with anti-VEGF might be of benefit in reducing the number of injections needed, but its long-term benefits remain unknown..
It is a kind of drug used to block the chemical growth in the eye. This medication is injected into the eye under local anaesthesia so that it does not hurt.
This is a new type of medication required to treat this condition. Common side effects of this medication include: eye irritation, eye pain, minor bleeding, and more.
It will destroy the blood vessels, and prevent the damage and will stop the macular degeneration from getting worse.
This kind of surgery is suitable if the abnormal blood vessels are not situated close to the fovea. The surgery is performed under local anaesthesia to numb the eye, and it is not painful.
We love to hear about our doctors, facilities
and your treatment at Medanta.
The User agrees and acknowledges that the User has read, understood and accepts the terms and conditions contained in the brochure provided with the Device (“Device”) with respect to its usage, operations, return / replacement and warranty policy.
The User hereby agrees and acknowledges that the Device (hardware and software) used in the provision
of services by Medanta is being provided on “as is” and “as available” basis through Alivecor India Private
Limited. Neither does Medanta endorse or promote the Device in any manner nor will Medanta be liable
for any claims, representations or warranties, whether express or implied as to the safety, reliability,
durability and performance of the device.
The services once availed cannot be cancelled except in cases where the User requests to cancel the service on the day of purchase in which case, full amount of service fees shall be refunded to the User provided that the Device has not been unboxed.
Before the expiry of service duration, the User can extend the services by availing various program options. For the said purposes, the User can call our helpline number +91 124 4141414 or visit www.medanta.org. The extended program availed by the User shall be activated automatically on expiry of existing program of services.
In cases where the User has opted for availing the Services through rented Device, a refundable deposit amount of ₹ 5,000 (“Deposit Amount”) shall be applicable and paid by the User. The refund of Deposit Amount shall be subject to return of the Device in working and undamaged condition. Refund of Deposit Amount shall be made through the same mode of payment as that of purchase in cases where the User personally visits the Medanta for returning the Device. If the User opts to return the Device through post, Deposit Amount shall be refunded electronically thorough NEFT or Bank transfer by Medanta within seven (7) working days of receipt of the Device and receipt of scanned image/copy of the ‘Cancelled Cheque’ of the User’s bank account.
Upon expiry of the services (either in terms of number of ECG or duration of the program) availed by the
User, the Device has to be returned within ten (10) days failing which the Deposit Amount shall be
Please note that the ECG pack or Refundable Device deposit are non-transferable from one patient to another.